Challenges with anti-PD1 agents in brain metastases management of NSCLC patients: a case report

Challenges with anti-PD1 agents in brain metastases management of NSCLC patients: a case report

Immunotherapy is dramatically changing the therapeutic landscape of advanced Non Small Cell Lung Cancer (NSCLC), with unprecedented results compared with chemotherapy. However, this novel treatment approach poses several novel challenges, including optimal treatment duration, coexistence with other...

Full description

Bibliographic Details
Main Authors: Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Alessandra Battaglia, Antonino Scimone, Vincenzo Adamo
Format: Article
Language:English
Published: Accademia Peloritana dei Pericolanti 2018-06-01
Series:Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche
Subjects:
NSCLC
Brain Metastasis
Nivolumab
Immunotherapy
Lung Cancer
Online Access:http://cab.unime.it/journals/index.php/APMB/article/view/1855

Internet

http://cab.unime.it/journals/index.php/APMB/article/view/1855

Similar Items